Matinas BioPharma Holdings
- Pharmaceutical Preparations
- Bedminster, New Jersey
Compensation history
Top executives at Matinas BioPharma Holdings received an average of $621K per person in annual compensation from 2014 to 2018.
Average pay of disclosed executives at Matinas BioPharma Holdings
By year
Executives
We found seven executives who work or worked at Matinas BioPharma Holdings.
Jerome Jabbour
Matinas BioPharma Holdings
Chief Executive Officer
Raphael Mannino
Matinas BioPharma Holdings
Chief Scientific Officer
Roelof Rongen
Matinas BioPharma Holdings
Chief Executive Officer
Gary Gaglione
Matinas BioPharma Holdings
Chief Financial Officer
Dominick DiPaolo
Matinas BioPharma Holdings
Former Senior Vice President, Quality and Regulatory Compliance
Douglas Kling
Matinas BioPharma Holdings
Senior Vice President, Clinical Development & Project Management
Abdel Fawzy
Matinas BioPharma Holdings
Executive Vice President, Supply Chain Development
News
About Matinas BioPharma Holdings
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address1545 Route 206 South, Suite 302, Bedminster, New Jersey 07921
- Phone908-443-1860
- Fiscal year endDecember 31
Source: SEC filings on September 24, 2019, September 24, 2018, September 14, 2017, and September 22, 2016.